Therefore, further validation of CHMP4C expression in prostate cancer, and whether CHMP4C affects the biological behavior of prostate cancer and the regulatory pathways involved, will help us to identify new biomarkers and new therapeutic options. The gene discussed is CHMP4C; the disease is Familial prostate cancer.